Pacific Biosciences Closes Acquisition of Omniome and Establishes San Diego Presence

Omniome’s high accuracy short-read sequencing platform expected to significantly expand PacBio’s market opportunity Acquisition expected to accelerate the adoption of SMRT Sequencing, PacBio’s leading long-read sequencing platform PacBio also closes $300 million PIPE financing in support of transaction MENLO PARK, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”),... Read more

Omniome Completes $60 Million Series B Financing To Advance Novel Genomic Sequencing Technology

SAN DIEGO, July 30, 2018 /PRNewswire/ — Omniome, Inc., developer of an innovative new DNA sequencing platform, today announced it has raised an additional $60 million with the completion of its Series B financing.  The funding round was led by Decheng Capital and Hillhouse Capital Group, joined by Lam Research Capital and Nan Fung Life Sciences as well as... Read more